200 related articles for article (PubMed ID: 37850268)
1. HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
Farias TDJ; Brugiapaglia S; Croci S; Magistroni P; Curcio C; Zguro K; Fallerini C; Fava F; Pettini F; Kichula KM; Pollock NR; Font-Porterias N; Palmer WH; Marin WM; Baldassarri M; Bruttini M; Hollenbach JA; Hendricks AE; Meloni I; Novelli F; ; Renieri A; Furini S; Norman PJ; Amoroso A
HLA; 2024 Jan; 103(1):e15251. PubMed ID: 37850268
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
3. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
Bernal E; Gimeno L; Alcaraz MJ; Quadeer AA; Moreno M; Martínez-Sánchez MV; Campillo JA; Gomez JM; Pelaez A; García E; Herranz M; Hernández-Olivo M; Martínez-Alfaro E; Alcaraz A; Muñoz Á; Cano A; McKay MR; Muro M; Minguela A
J Infect Dis; 2021 Jul; 224(2):229-240. PubMed ID: 33928374
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid.
Balas A; Moreno-Hidalgo MÁ; de la Calle-Prieto F; Vicario JL; Arsuaga M; Trigo E; de Miguel-Buckley R; Bellón T; Díaz-Menéndez M
Hum Immunol; 2023 Nov; 84(11):571-577. PubMed ID: 37777360
[TBL] [Abstract][Full Text] [Related]
5. HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
Wang R; Sun Y; Kuang BH; Yan X; Lei J; Lin YX; Tian J; Li Y; Xie X; Chen T; Zhang H; Zeng YX; Zhao J; Feng L
Emerg Microbes Infect; 2023 Dec; 12(1):2185467. PubMed ID: 36849422
[TBL] [Abstract][Full Text] [Related]
6. The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province.
Kakodkar P; Dokouhaki P; Wu F; Shavadia J; Nair R; Webster D; Sawyer T; Huan T; Mostafa A
Hum Immunol; 2023 Mar; 84(3):163-171. PubMed ID: 36707385
[TBL] [Abstract][Full Text] [Related]
7. Association of KIR gene polymorphisms with COVID-19 disease.
Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
Clin Immunol; 2022 Jan; 234():108911. PubMed ID: 34929414
[TBL] [Abstract][Full Text] [Related]
8. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
Front Genet; 2022; 13():845474. PubMed ID: 35273641
[No Abstract] [Full Text] [Related]
9. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.
Taniguchi M; Kawabata M
Immunogenetics; 2009 Dec; 61(11-12):717-30. PubMed ID: 19859704
[TBL] [Abstract][Full Text] [Related]
10. Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children.
Singh KK; Qin M; Brummel SS; Angelidou K; Trout RN; Fenton T; Spector SA
PLoS One; 2016; 11(3):e0151364. PubMed ID: 26983081
[TBL] [Abstract][Full Text] [Related]
11. Protective KIR-HLA interactions for HCV infection in intravenous drug users.
Zúñiga J; Romero V; Azocar J; Terreros D; Vargas-Rojas MI; Torres-García D; Jiménez-Alvarez L; Vargas-Alarcón G; Granados-Montiel J; Husain Z; Chung RT; Alper CA; Yunis EJ
Mol Immunol; 2009 Aug; 46(13):2723-7. PubMed ID: 19552960
[TBL] [Abstract][Full Text] [Related]
12. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
13. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease.
Castaño-Núñez Á; Montes-Cano MA; García-Lozano JR; Ortego-Centeno N; García-Hernández FJ; Espinosa G; Graña-Gil G; Sánchez-Bursón J; Juliá MR; Solans R; Blanco R; Barnosi-Marín AC; Gómez de la Torre R; Fanlo P; Rodríguez-Carballeira M; Rodríguez-Rodríguez L; Camps T; Castañeda S; Alegre-Sancho JJ; Martín J; González-Escribano MF
Front Immunol; 2019; 10():2755. PubMed ID: 31849952
[TBL] [Abstract][Full Text] [Related]
14. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
15. KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors.
Alicata C; Ashouri E; Nemat-Gorgani N; Guethlein LA; Marin WM; Tao S; Moretta L; Hollenbach JA; Trowsdale J; Traherne JA; Ghaderi A; Parham P; Norman PJ
Front Immunol; 2020; 11():556. PubMed ID: 32300348
[TBL] [Abstract][Full Text] [Related]
16. HLA Alleles and KIR Genes in Romanian Patients with Chronic Hepatitis C.
Ursu L; Calenic B; Diculescu M; Dima A; Constantinescu I
J Gastrointestin Liver Dis; 2020 Oct; 29(4):595-601. PubMed ID: 33118540
[TBL] [Abstract][Full Text] [Related]
17. Allelic Polymorphisms of
Ureshino H; Shindo T; Kojima H; Kusunoki Y; Miyazaki Y; Tanaka H; Saji H; Kawaguchi A; Kimura S
Cancer Immunol Res; 2018 Jun; 6(6):745-754. PubMed ID: 29695383
[TBL] [Abstract][Full Text] [Related]
18. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
Front Immunol; 2022; 13():922252. PubMed ID: 35911762
[TBL] [Abstract][Full Text] [Related]
19. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
